BioCardia raises ~$570K in private placement of stock and warrants

BioCardia, Inc.

Sold 274,696 shares and warrants at $2.075/unit, gross proceeds ~$570,000.
Warrants exercisable at $1.95/share until 6/30/2030 or PMDA approval of CardiAMP.
Directors/officers invested $360K, including CEO Peter Altman ($50K) and CFO David McClung ($10K).
Proceeds for general corporate purposes; registration statement to be filed by July 10, 2025.

item 3.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.